| 19th May 2021 4:37 pm |
RNS |
Exercise of options and total voting rights |
| 11th May 2021 7:00 am |
RNS |
Parsortix study uncovers targets in TNBC patients |
| 30th Apr 2021 11:22 am |
RNS |
Exercise of options and total voting rights |
| 29th Apr 2021 7:00 am |
RNS |
Preliminary Results |
| 26th Apr 2021 7:00 am |
RNS |
Ovarian cancer study patient enrolment completed |
| 19th Apr 2021 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 19th Apr 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 19th Apr 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 19th Apr 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 16th Apr 2021 7:00 am |
RNS |
First large-scale pharma services contract secured |
| 15th Apr 2021 4:10 pm |
RNS |
Notice of Preliminary Results and Webcast |
| 12th Apr 2021 7:00 am |
RNS |
ANGLE's Parsortix system showcased at AACR 2021 |
| 30th Mar 2021 7:00 am |
RNS |
Global launch of clinical services laboratories |
| 4th Mar 2021 7:00 am |
RNS |
Update on submission for FDA clearance |
| 18th Feb 2021 7:00 am |
RNS |
Parsortix-harvested CTCs uncover novel biomarker |
| 8th Feb 2021 7:00 am |
RNS |
Parsortix: Dynamic assessment of patient response |
| 29th Jan 2021 7:00 am |
RNS |
Parsortix demonstrates high capture rate of CTCs |
| 26th Jan 2021 1:00 pm |
RNS |
Holding(s) in Company |
| 20th Jan 2021 7:00 am |
RNS |
Research confirms high performance of Parsortix |
| 12th Jan 2021 7:00 am |
RNS |
Change of Auditor |
| 5th Jan 2021 7:00 am |
RNS |
Issue of Equity |
| 9th Dec 2020 7:00 am |
RNS |
Parsortix can capture single cancer cell in sample |
| 20th Nov 2020 4:18 pm |
RNS |
Holding(s) in Company |
| 18th Nov 2020 4:51 pm |
RNS |
Holding(s) in Company |
| 13th Nov 2020 10:46 am |
RNS |
Result of General Meeting |
| 3rd Nov 2020 2:54 pm |
RNS |
Director/PDMR Shareholding |
| 29th Oct 2020 7:00 am |
RNS |
Interim Results |
| 27th Oct 2020 6:28 pm |
RNS |
Result of Placing & Notice of General Meeting |
| 27th Oct 2020 7:00 am |
RNS |
Accelerated bookbuild to raise up to £20m |
| 20th Oct 2020 7:00 am |
RNS |
Submission accepted by FDA for substantive review |
| 28th Sep 2020 7:00 am |
RNS |
Issue of LTIP Options and Share Options |
| 28th Sep 2020 7:00 am |
RNS |
ANGLE announces completion of FDA submission |
| 23rd Sep 2020 7:00 am |
RNS |
Potential treatment strategy to limit metastasis |
| 11th Sep 2020 3:35 pm |
RNS |
Holding(s) in Company |
| 11th Sep 2020 3:30 pm |
RNS |
Holding(s) in Company |
| 2nd Sep 2020 1:49 pm |
RNS |
Notification of Interim Results and Webcast |
| 2nd Sep 2020 10:00 am |
RNS |
Holding(s) in Company |
| 27th Aug 2020 3:13 pm |
RNS |
Result of 2020 Annual General Meeting |
| 18th Aug 2020 9:30 am |
RNS |
Holding(s) in Company |
| 14th Aug 2020 7:00 am |
RNS |
Parsortix use to assess response to immunotherapy |
